Epidemiologic aspects in prevention of the new coronavirus infection (COVID-19) (Literature review)

View or download the full article: 

T.M. Butaev1, A.S. Tsirikhova1, D.V. Kabaloeva1, D.O. Kudukhova1,2


1North-Ossetian State Medical Academy, 40 Pushkinskaya Str., Vladikavkaz, 362019, Russian Federation
2 The Federal Service for Surveillance over Consumer Rights Protection and Human Well-being, Regional office in the Republic of North Ossetia Alania, 17A Tel'mana Str., Vladikavkaz, 362021, Russian Federation


At the end of 2019 the mankind had to face a new coronavirus infection with higher virulence which resulted in its rapid spread all over the world and in an ultimate pandemic. Initially a new virus which causes COVID-19 was called 2019-nCoV but it soon acquired its well-known name, SARS-CoV-2. We can positively state that this new coronavirus infection will remain in the history of world public healthcare as a disease that caused a collapse in rendering medical aid. Undoubtedly, this new coro-navirus infection has changed customary lifestyle of the overall world population.
This review can be considered problematic in its essence and focuses on examining contemporary trends in the official epidemiologic situation in the world regarding the new coronavirus infection (SARS-CoV-2). Having analyzed several foreign and domestic documents, the authors revealed a necessity to enhance levels and quality of COVID-19 epidemiologic diagnostics. There is a suggestion being considered at the moment on including additional clinical and diagnostic activities aimed at preventing further spread of the new coronavirus infection. We should note that data on COVID-19-related mortality and morbidity are renewed every day and every hour. Given that, it seems rather difficult to keep in line with the latest trends in COVID-19 prevention and epidemiologic diagnostics. However, the authors made an attempt to possibly collect all the latest data on epidemiological peculiarities related to the clinical course of the new coronavirus infection. The authors have a hope that this review will be useful for epidemiologists when they detect new cases of the disease as well as for lecturers at medical higher educational establishments when they train students and resident physicians.

new coronavirus infection, SARS-CoV-2, COVID-19, basic reproductive number, pandemic, severe acute respiratory syndrome – SARS, children, pregnant women, fecal-oral transmission, prevention
Butaev T.M., Tsirikhova A.S., Kabaloeva D.V., Kudukhova D.O. Epidemiologic aspects in prevention of the new coronavirus infection (COVID-19) (Literature review). Health Risk Analysis, 2022, no. 1, pp. 176–185. DOI: 10.21668/health.risk/2022.1.19.eng
  1. Akin L., Gözel M.G. Understanding dynamics of pandemics. Turk. J. Med. Sci., 2020, vol. 50, no. SI-1, pp. 515–519. DOI: 10.3906/sag-2004-133
  2. Potter C.W. A history of influenza. Journal of Applied Microbiology, 2001, vol. 91, no. 4, pp. 572–579. DOI: 10.1046/j.1365-2672.2001.01492.x
  3. Arda B., Acıduman A. Pandemic influenza 1918-19: lessons from 20th century to the 21st from the history of medicine point of view. Lokman Hekim Journal, 2012, vol. 2, no. 3, pp. 13–21.
  4. Chen B., Tian E.-K., He B., Tian L., Han R., Wang S., Xiang Q., Zhang S. [et al.]. Overview of lethal human coronaviruses. Signal Transduct. Target. Ther., 2020, vol. 5, no. 1, pp. 89. DOI: 10.1038/s41392-020-0190-2
  5. Hozhabri H., Piceci Sparascio F., Sohrabi H., Mousavifar L., Roy R., Scribano D., De Luca A., Ambrosi C., Sarshar M. The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting. Int. J. Environ. Res. Public Health, 2020, vol. 17, no. 16, pp. 5648. DOI: 10.3390/ijerph17165648
  6. Chen Y., Liu Q., Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol., 2020, vol. 92, no. 4, pp. 418–423. DOI: 10.1002/jmv.25681
  7. Hassan S.A., Sheikh F.N., Jamal S., Ezeh J.K., Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus, 2020, vol. 12, no. 3, pp. e7355. DOI: 10.7759/cureus.7355
  8. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B. [et al.]. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med., 2020, vol. 382, no. 8, pp. 727–733. DOI: 10.1056/NEJMoa2001017A
  9. Lu H., Stratton C.W., Tang Y.W. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J. Med. Virol., 2020, vol. 92, no. 4, pp. 401–402. DOI: 10.1002/jmv.25678
  10. Ashour H.M., Elkhatib W.F., Rahman M.M., Elshabrawy H.A. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Pathogens, 2020, vol. 9, no. 3, pp. 186. DOI: 10.3390/pathogens9030186
  11. Weston S., Frieman M.B. COVID-19: Knowns, Unknowns, and Questions. mSphere, 2020, vol. 5, no. 2, pp. e00203–e00220. DOI: 10.1128/mSphere.00203-20
    1. Hijawi B., Abdallat M., Sayaydeh A., Alqasrawi S., Haddadin A., Jaarour N., Alsheikh S., Alsanouri T. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr. Health J., 2013, vol. 19, Suppl. 1, pp. S12–S18.
  12. De Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol., 2016, vol. 14, no. 8, pp. 523–534. DOI: 10.1038/nrmicro.2016.81
  13. Drexler J.F., Corman V.M., Drosten C. Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. Antiviral Res., 2014, vol. 101, pp. 45–56. DOI: 10.1016/j.antiviral.2013.10.013
  14. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J. Pediatr., 2020, vol. 87, no. 4, pp. 281–286. DOI: 10.1007/s12098-020-03263-6
  15. Zhou P., Yang X.-L., Wang X.-G., Hu B., Zhang L., Zhang W., Si H.-R., Zhu Y. [et al.]. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, vol. 579, no. 7798, pp. 270–273. DOI: 10.1038/s41586-020-2012-7
  16. Shamsheva O.V. New Coronavirus COVID-19 (SARS-CoV-2). Detskie infektsii, 2020, vol. 19, no. 1, pp. 5–6. DOI: 10.22627/2072-8107-2020-19-1-5-6 (in Russian).
  17. Perlman S. Another Decade, Another Coronavirus. N. Engl. J. Med., 2020, vol. 382, no. 8, pp. 760–762. DOI: 10.1056/NEJMe2001126
  18. Haagmans B.L., van den Brand J.M.A., Raj V.S., Volz A., Wohlsein P., Smits S.L., Schipper D., Bestebroer T.M. [et al.]. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science, 2016, vol. 351, no. 6268, pp. 77–81. DOI: 10.1126/science.aad1283
  19. Sanche S., Lin Y.T., Xu C., Romero-Severson E., Hengartner N., Ke R. High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg. Infect. Dis., 2020, vol. 26, no. 7, pp. 1470–1477. DOI: 10.3201/eid2607.200282
  20. CORONAVIRUS (COVID-19). Available at: https://coronavirus-monitor.ru (03.11.2020) (in Russian).
  21. Li J., Blakeley D., Smith R.J. The failure of R0. Computational and mathematical methods in medicine, 2011. Available at: http://downloads.hindawi.com/journals/cmmm/2011/527610.pdf (17.08.2021).
  22. Liu Y., Gayle A.A., Wilder-Smith A., Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med., 2020, vol. 27, no. 2, pp. taaa021. DOI: 10.1093/jtm/taaa021
  23. Ge H., Wang X., Yuan X., Xiao G., Wang C., Deng T., Yuan Q., Xiao X. The epidemiology and clinical information about COVID-19. Eur. J. Clin. Microbiol. Infect. Dis., 2020, vol. 39, no. 6, pp. 1011–1019. DOI: 10.1007/s10096-020-03874-z
  24. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R., Leung K.S.M. [et al.]. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med., 2020, vol. 382, no. 13, pp. 1199–1207. DOI: 10.1056/NEJMoa2001316
  25. Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V. [et al.]. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N. Engl. J. Med., 2020, vol. 382, no. 10, pp. 970–971. DOI: 10.1056/NEJMc2001468
  26. Cheng Z.J., Shan J. 2019 Novel coronavirus: where we are and what we know. Infection, 2020, vol. 48, no. 2, pp. 155–163. DOI: 10.1007/s15010-020-01401-y
  27. Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H.R., Azman A.S., Reich N.G., Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of internal medicine, 2020, vol. 172, no. 9, pp. 577–582. DOI: 10.7326/M20-0504
  28. Bulut C., Kato Y. Epidemiology of COVID-19. Turk. J. Med. Sci., 2020, vol. 50, no. SI–1, pp. 563–570. DOI: 10.3906/sag-2004-172
  29. Cheng V.C.C., Wong S.C., Chen J.H.K., Yip C.C.Y., Chuang V.W.M., Tsang O.T.Y., Sridhar S., Chan J.F.W. [et al.]. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect. Control Hosp. Epidemiol., 2020, vol. 41, no. 5, pp. 493–498. DOI: 10.1017/ice.2020.58
  30. Machhi J., Herskovitz J., Senan A.M., Dutta D., Nath B., Oleynikov M.D., Blomberg W.R., Meigs D.D. [et al.]. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections. J. Neuroimmune Pharmacol., 2020, vol. 15, no. 3, pp. 359–386. DOI: 10.1007/s11481-020-09944-5
  31. Kampf G., Todt D., Pfaender S., Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect., 2020, vol. 104, no. 3, pp. 246–251. DOI: 10.1016/j.jhin.2020.01.022
  32. Dhama K., Khan S., Tiwari R., Sircar S., Bhat S., Malik Y.S., Singh K.P., Chaicumpa W. [et al.]. Coronavirus Disease 2019-COVID-19. Clinical microbiology reviews, 2020, vol. 33, no. 4, pp. e00028–20. DOI: 10.1128/CMR.00028-20
  33. Schwartz D.A. An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch. Pathol. Lab. Med., 2020, vol. 144, no. 7, pp. 799–805. DOI: 10.5858/arpa.2020-0901-SA
  34. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D. [et al.]. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet, 2020, vol. 395, no. 10226, pp. 809–815. DOI: 10.1016/S0140-6736(20)30360-3
  35. Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immuni-ty, inflammation and intervention. Nat. Rev. Immunol., 2020, vol. 20, no. 6, pp. 363–374. DOI: 10.1038/s41577-020-0311-8
  36. Rasmussen S.A., Smulian J.C., Lednicky J.A., Wen T.S., Jamieson D.J. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am. J. Obstet. Gynecol., 2020, vol. 222, no. 5, pp. 415–426. DOI: 10.1016/j.ajog.2020.02.017
  37. Haybar H., Kazemnia K., Rahim F. Underlying chronic disease and COVID-19 infection: A State-of-the-Art Review. Jundishapur J. Chronic Dis. Care, 2020, vol. 9, no. 2, pp. e103452. DOI: 10.5812/jjcdc.103452
  38. Ghinai I., McPherson T.D., Hunter J.C., Kirking H.L., Christiansen D., Joshi K., Rubin R., Morales-Estrada S. [et al.]. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet, 2020, vol. 395, no. 10230, pp. 1137–1144. DOI: 10.1016/S0140-6736(20)30607-3
  39. Harmooshi N.N., Shirbandi K., Rahim F. Environmental concern regarding the effect of humidity and temperature on 2019-nCoV survival: fact or fiction. Environ. Sci. Pollut. Res. Int., 2020, vol. 27, no. 29, pp. 36027–36036. DOI: 10.1007/s11356-020-09733-w
  40. Ye Q., Wang B., Mao J., Fu J., Shang S., Shu Q., Zhang T. Epidemiological analysis of COVID-19 and practical experience from China. J. Med. Virol., 2020, vol. 92, no. 7, pp. 755–769. DOI: 10.1002/jmv.25813
  41. Chen W., Wang Q., Li Y.Q., Yu H.L., Xia Y.Y., Zhang M.L., Qin Y., Zhang T. [et al.]. [Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China]. Zhonghua Yu Fang Yi Xue Za Zhi, 2020, vol. 54, no. 3, pp. 239–244. DOI: 10.3760/cma.j.issn.0253-9624.2020.03.003 (in Chinese).
  42. Chen S., Yang J., Yang W., Wang C., Bärnighausen T. COVID-19 control in China during mass population movements at New Year. Lancet, 2020, vol. 395, no. 10226, pp. 764–766. DOI: 10.1016/S0140-6736(20)30421-9
  43. Patel A., Jernigan D.B. 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak – United States, December 31, 2019–February 4, 2020. MMWR Morb. Mortal. Wkly Rep., 2020, vol. 69, no. 5, pp. 140–146. DOI: 10.15585/mmwr.mm6905e145
  44. Yu J., Chai P., Ge S., Fan X. Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside. Front. Cell Dev. Biol., 2020, vol. 8, no. 476, pp. 476. DOI: 10.3389/fcell.2020.00476
  45. Wang J., Tang K., Feng K., Lv W. High temperature and high humidity reduce the transmission of COVID-19. Available at: https://ssrn.com/abstract=3551767 (17.07.2021).
  46. Malik Y.S., Kumar N., Sircar S., Kaushik R., Bhat S., Dhama K., Gupta P., Goyal K. [et al.]. Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. Pathogens, 2020, vol. 9, no. 7, pp. 519. DOI: 10.3390/pathogens9070519
  47. Viboud C., Santillana M. Fitbit-informed influenza forecasts. Lancet Digit. Health, 2020, vol. 2, no. 2, pp. e54–e55. DOI: 10.1016/S2589-7500(19)30241-9
  48. Radin J.M., Wineinger N.E., Topol E.J., Steinhubl S.R. Harnessing wearable device data to improve state-level real-time surveillance of influenza-like illness in the USA: A population-based study. Lancet Digit. Health, 2020, vol. 2, no. 2, pp. e85–e93. DOI: 10.1016/S2589-7500(19)30222-5
Accepted for publication: 

You are here